Radiomic signature predicts clinical outcomes in patients with gliomas

Takeaway 

  • In a retrospective analysis, a radiomic imaging signature predicted individual progression-free survival in patients with lower-grade gliomas. 

Why this matters

    Lower-grade gliomas are heterogeneous and result in a wide range of progression-free survival (PFS). A specific imaging signature could predict PFS and inform treatment decisions.